871 related articles for article (PubMed ID: 1696859)
1. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
[TBL] [Abstract][Full Text] [Related]
2. Effect of azidothymidine (AZT) on HIV P24 antigen, beta 2-microglobulin, neopterin, soluble CD8, soluble interleukin-2 receptor and tumor necrosis factor alpha levels in patients with AIDS-related complex or AIDS.
Reddy MM; McKinley G; Englard A; Grieco MH
Int J Immunopharmacol; 1990; 12(7):737-41. PubMed ID: 2127261
[TBL] [Abstract][Full Text] [Related]
3. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine.
Williams IG; Gabriel G; Kelly G; Loveday C; Tedder RS; Weller IV
AIDS; 1990 Sep; 4(9):909-12. PubMed ID: 2123627
[TBL] [Abstract][Full Text] [Related]
4. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
[TBL] [Abstract][Full Text] [Related]
5. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
6. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
[TBL] [Abstract][Full Text] [Related]
7. T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping.
Plaeger-Marshall S; Isacescu V; O'Rourke S; Bertolli J; Bryson YJ; Stiehm ER
Clin Immunol Immunopathol; 1994 Apr; 71(1):19-26. PubMed ID: 7511081
[TBL] [Abstract][Full Text] [Related]
8. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE
AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study.
Giorgi JV; Liu Z; Hultin LE; Cumberland WG; Hennessey K; Detels R
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):904-12. PubMed ID: 7686224
[TBL] [Abstract][Full Text] [Related]
10. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
Li T; Qiu Z; Wang A; Sheng R
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
[TBL] [Abstract][Full Text] [Related]
11. Two-year evaluation of clinical and laboratory variables of immune function in 117 hemophiliacs seropositive or seronegative for HIV-1.
Teitel JM; Freedman JJ; Garvey MB; Kardish M
Am J Hematol; 1989 Dec; 32(4):262-72. PubMed ID: 2573270
[TBL] [Abstract][Full Text] [Related]
12. Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine.
Jacobson MA; Abrams DI; Volberding PA; Bacchetti P; Wilber J; Chaisson RE; Crowe S; Howard W; Moss A
J Infect Dis; 1989 Jun; 159(6):1029-36. PubMed ID: 2566637
[TBL] [Abstract][Full Text] [Related]
13. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
[TBL] [Abstract][Full Text] [Related]
14. Changes in the level of blood suppressor CD8+CD57+ lymphocytes, when HIV-1 p24 antigen reappears in the blood.
Mathé G; Morette C; Hallard M; Sala M; Orbach-Arbouys S
Biomed Pharmacother; 1994; 48(1):3-5. PubMed ID: 7522602
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
16. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS.
Reddy MM; McKinley G; Englard A; Grieco MH
J Clin Lab Anal; 1989; 3(4):199-201. PubMed ID: 2503599
[TBL] [Abstract][Full Text] [Related]
17. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
[TBL] [Abstract][Full Text] [Related]
18. Didanosine therapy in patients intolerant of or failing zidovudine therapy.
Rathbun RC; Martin ES
Ann Pharmacother; 1992 Nov; 26(11):1347-51. PubMed ID: 1362093
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail.
Parks WP; Parks ES; Fischl MA; Leuther MD; Allain JP; Nusinoff-Lehrman S; Barry DW; Makuch RW
J Acquir Immune Defic Syndr (1988); 1988; 1(2):125-30. PubMed ID: 3145972
[TBL] [Abstract][Full Text] [Related]
20. CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy.
Yacyshyn MB; Poppema S; Berg A; MacLean GD; Reddish MA; Meikle A; Longenecker BM
Int J Cancer; 1995 May; 61(4):470-4. PubMed ID: 7538976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
